Skip to main content
Caplight Logo









Alvion Pharmaceuticals

Alvion Pharmaceuticals

Private
AthensHealthcare & Life Scienceshttps://alvionpharma.com/

Last Round

Strategic

Apr 1, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Alvion Pharmaceuticals is a pharmaceutical company that develops and manufactures complex generic and value-added medicines for global markets.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Compliance

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

generic pharmaceuticalsvalue-added medicinespharma licensingpharmaceutical out-licensingpharmaceutical supplyintellectual property licensingcontract developmentcomplex genericsregulatory affairsanalytical supportdrug developmentcontract development and manufacturing organizationCDMOnon-infringing formulationsIP powerhouse

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alvion Pharmaceuticals Comparables

Compare Alvion Pharmaceuticals with similar companies based on industry and business-model similarity.

Alvion Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Adalvo
85%
Coripharma
85%
V-Ensure Pharma Technologies
80%

Alvion Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicApr 1, 2026

Key People

Founding team and executive leadership

John Bouros

CEO

Executive Team

Alvion Pharmaceuticals Investors

Notable investors and investment history

Alvion Pharmaceuticals investors
InvestorRounds
iGrow Venture PartnersStrategic

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 231% MoM, reaching 1.8K.

  • May 5, 2026

    Grew 29% QoQ, from 17 to 22 employees.

Alvion Pharmaceuticals Filings

Explore SEC and related filing metadata, where available.

Alvion Pharmaceuticals filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Alvion Pharmaceuticals's valuation, stock price, and market status.

Is Alvion Pharmaceuticals a public or private company?

Alvion Pharmaceuticals is a private company.

What is the current stock price of Alvion Pharmaceuticals?

Alvion Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.

How much is Alvion Pharmaceuticals worth (valuation)?

Valuation information for Alvion Pharmaceuticals is not publicly available.

Can I buy Alvion Pharmaceuticals stock?

Alvion Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Alvion Pharmaceuticals's last funding round?

Alvion Pharmaceuticals's most recent funding round was Strategic on April 1, 2026.

Who are the main investors in Alvion Pharmaceuticals?

Key investors in Alvion Pharmaceuticals include iGrow Venture Partners.

Will Alvion Pharmaceuticals IPO soon?

No public IPO plans have been announced for Alvion Pharmaceuticals.

How can I track Alvion Pharmaceuticals secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Alvion Pharmaceuticals's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAthens
Employee Range12
Year Founded2013
Last FundingApr 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?